BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 26162096)

  • 1. AMPK Signaling Involvement for the Repression of the IL-1β-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs.
    El Hadri K; Denoyelle C; Ravaux L; Viollet B; Foretz M; Friguet B; Rouis M; Raymondjean M
    PLoS One; 2015; 10(7):e0132498. PubMed ID: 26162096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of interleukin-1beta-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPARbeta and the proto-oncogene BCL-6.
    Ravaux L; Denoyelle C; Monne C; Limon I; Raymondjean M; El Hadri K
    Mol Cell Biol; 2007 Dec; 27(23):8374-87. PubMed ID: 17908795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine and paracrine transcriptional regulation of type IIA secretory phospholipase A2 gene in vascular smooth muscle cells.
    Jaulmes A; Janvier B; Andreani M; Raymondjean M
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1161-7. PubMed ID: 15802623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation.
    Nagata D; Takeda R; Sata M; Satonaka H; Suzuki E; Nagano T; Hirata Y
    Circulation; 2004 Jul; 110(4):444-51. PubMed ID: 15262850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Statins and Xuezhikang on the Expression of Secretory Phospholipase A2, Group IIA in Rat Vascular Smooth Muscle Cells.
    Xie Q; Zhang D
    Int Heart J; 2017 Feb; 58(1):115-124. PubMed ID: 28123160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AICAR induces cyclooxygenase-2 expression through AMP-activated protein kinase-transforming growth factor-beta-activated kinase 1-p38 mitogen-activated protein kinase signaling pathway.
    Chang MY; Ho FM; Wang JS; Kang HC; Chang Y; Ye ZX; Lin WW
    Biochem Pharmacol; 2010 Oct; 80(8):1210-20. PubMed ID: 20615388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretory phospholipase A2, group IIA is a novel serum amyloid A target gene: activation of smooth muscle cell expression by an interleukin-1 receptor-independent mechanism.
    Sullivan CP; Seidl SE; Rich CB; Raymondjean M; Schreiber BM
    J Biol Chem; 2010 Jan; 285(1):565-75. PubMed ID: 19850938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1beta in vascular smooth muscle cells: interplay of the CCAAT/enhancer binding protein (C/EBP), nuclear factor-kappaB and Ets transcription factors.
    Antonio V; Brouillet A; Janvier B; Monne C; Bereziat G; Andreani M; Raymondjean M
    Biochem J; 2002 Dec; 368(Pt 2):415-24. PubMed ID: 12188923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of LKB1 and AMPK-related kinases in skeletal muscle: effects of contraction, phenformin, and AICAR.
    Sakamoto K; Göransson O; Hardie DG; Alessi DR
    Am J Physiol Endocrinol Metab; 2004 Aug; 287(2):E310-7. PubMed ID: 15068958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation.
    Luchtefeld M; Bandlow N; Tietge UJ; Grote K; Pfeilschifter J; Kaszkin M; Beck S; Drexler H; Schieffer B
    Atherosclerosis; 2007 Sep; 194(1):62-70. PubMed ID: 17069818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells.
    Turban S; Stretton C; Drouin O; Green CJ; Watson ML; Gray A; Ross F; Lantier L; Viollet B; Hardie DG; Marette A; Hundal HS
    J Biol Chem; 2012 Jun; 287(24):20088-99. PubMed ID: 22511782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMP-activated kinase relaxes agonist induced contractions in the mouse aorta via effects on PKC signaling and inhibits NO-induced relaxation.
    Davis B; Rahman A; Arner A
    Eur J Pharmacol; 2012 Nov; 695(1-3):88-95. PubMed ID: 22921370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory activities of fenoterol through β-arrestin-2 and inhibition of AMPK and NF-κB activation in AICAR-induced THP-1 cells.
    Wang W; Chen J; Li XG; Xu J
    Biomed Pharmacother; 2016 Dec; 84():185-190. PubMed ID: 27657826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide stress and activation of AMP-activated protein kinase impair β-cell sarcoendoplasmic reticulum calcium ATPase 2b activity and protein stability.
    Tong X; Kono T; Evans-Molina C
    Cell Death Dis; 2015 Jun; 6(6):e1790. PubMed ID: 26086963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation and induction of cytosolic phospholipase A2 by IL-1beta in human tracheal smooth muscle cells: role of MAPKs/p300 and NF-kappaB.
    Lee CW; Lee IT; Lin CC; Lee HC; Lin WN; Yang CM
    J Cell Biochem; 2010 Apr; 109(5):1045-56. PubMed ID: 20069553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPK activation attenuates inflammatory pain through inhibiting NF-κB activation and IL-1β expression.
    Xiang HC; Lin LX; Hu XF; Zhu H; Li HP; Zhang RY; Hu L; Liu WT; Zhao YL; Shu Y; Pan HL; Li M
    J Neuroinflammation; 2019 Feb; 16(1):34. PubMed ID: 30755236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of sPLA2-IIA and PGE2 production by high mobility group protein B1 in vascular smooth muscle cells sensitized by IL-1beta.
    Jaulmes A; Thierry S; Janvier B; Raymondjean M; Maréchal V
    FASEB J; 2006 Aug; 20(10):1727-9. PubMed ID: 16807371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-aminoimidazole-4-carboxamide ribonucleoside and AMP-activated protein kinase inhibit signalling through NF-κB.
    Katerelos M; Mudge SJ; Stapleton D; Auwardt RB; Fraser SA; Chen CG; Kemp BE; Power DA
    Immunol Cell Biol; 2010 Oct; 88(7):754-60. PubMed ID: 20404837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression.
    Igata M; Motoshima H; Tsuruzoe K; Kojima K; Matsumura T; Kondo T; Taguchi T; Nakamaru K; Yano M; Kukidome D; Matsumoto K; Toyonaga T; Asano T; Nishikawa T; Araki E
    Circ Res; 2005 Oct; 97(8):837-44. PubMed ID: 16151020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Search of factors that intermediate cytokine-induced group IIA phospholipase A2 expression through the cytosolic phospholipase A2- and 12/15-lipoxygenase-dependent pathway.
    Kuwata H; Nonaka T; Murakami M; Kudo I
    J Biol Chem; 2005 Jul; 280(27):25830-9. PubMed ID: 15878884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.